These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 22609204)
1. Wnt5a signaling is a substantial constituent in bone morphogenetic protein-2-mediated osteoblastogenesis. Nemoto E; Ebe Y; Kanaya S; Tsuchiya M; Nakamura T; Tamura M; Shimauchi H Biochem Biophys Res Commun; 2012 Jun; 422(4):627-32. PubMed ID: 22609204 [TBL] [Abstract][Full Text] [Related]
3. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592 [TBL] [Abstract][Full Text] [Related]
4. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling. Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925 [TBL] [Abstract][Full Text] [Related]
5. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266 [TBL] [Abstract][Full Text] [Related]
6. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. Nakashima A; Katagiri T; Tamura M J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699 [TBL] [Abstract][Full Text] [Related]
7. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2. Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788 [TBL] [Abstract][Full Text] [Related]
8. The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification. Xin H; Xin F; Zhou S; Guan S Int J Mol Med; 2013 Mar; 31(3):583-8. PubMed ID: 23337931 [TBL] [Abstract][Full Text] [Related]
9. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. Sonomoto K; Yamaoka K; Oshita K; Fukuyo S; Zhang X; Nakano K; Okada Y; Tanaka Y Arthritis Rheum; 2012 Oct; 64(10):3355-63. PubMed ID: 22674197 [TBL] [Abstract][Full Text] [Related]
11. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
14. Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism. Li J; Khavandgar Z; Lin SH; Murshed M Bone; 2011 Feb; 48(2):321-31. PubMed ID: 20932949 [TBL] [Abstract][Full Text] [Related]
15. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895 [TBL] [Abstract][Full Text] [Related]
16. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005 [TBL] [Abstract][Full Text] [Related]
17. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. Park KH; Kang JW; Lee EM; Kim JS; Rhee YH; Kim M; Jeong SJ; Park YG; Kim SH J Pineal Res; 2011 Sep; 51(2):187-94. PubMed ID: 21470302 [TBL] [Abstract][Full Text] [Related]
18. Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling. Yang T; Zhang J; Cao Y; Zhang M; Jing L; Jiao K; Yu S; Chang W; Chen D; Wang M J Dent Res; 2015 Jun; 94(6):803-12. PubMed ID: 25749876 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632 [TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]